Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
Treatment satisfaction in multiple sclerosis.
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
199 Outcomes after microvascular decompression for patients with trigeminal neuralgia and suspected multiple sclerosis.
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Role of regulatory b cells in neuroimmunologic disorders.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
Regenerative cellular therapies for neurologic diseases.
Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Monoclonal antibodies in MS: mechanisms of action.
Spectrum of nontraumatic myelopathies in Ethiopian patients: hospital-based retrospective study.
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience.
Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab)
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
Interferon-beta(1b) treatment in neuromyelitis optica.
Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells.
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.

Pages